Skip to main content

Sex Differences Seen in Cognitive Impairment for Tardive Dyskinesia in Schizophrenia

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

FRIDAY, May 19, 2023 -- For schizophrenia patients with tardive dyskinesia (TD), there may be sex differences in cognitive impairment, with a protective effect suggested by female gender, according to a study published in the May issue of Schizophrenia Research.

Wanni Zhang, from Capital Normal University in Beijing, and colleagues recruited 496 schizophrenia inpatients and 362 healthy controls to examine sex differences in cognitive performance in schizophrenia patients with TD. Psychopathological symptoms were assessed using the Positive and Negative Syndrome Scale (PANSS), and the severity of TD was measured using the Abnormal Involuntary Movement Scale (AIMS). The Repeatable Battery for Assessment of Neuropsychological Status (RBANS) was used to measure cognitive function in 313 and 310 of the patients and healthy controls, respectively.

The researchers found that compared with healthy controls, patients with schizophrenia performed worse in all cognitive domains. Patients with TD had higher PANSS total, PANSS negative symptom subscale, and AIMS scores than those without TD, as well as significantly lower RBANS total, visuospatial/constructional, and attention subscale scores. In male patients with TD, the visuospatial/constructional and attention indices remained significantly lower than those seen in patients without TD, while for female patients, these results were not observed. In male patients only, there was a negative correlation seen for visuospatial/constructional and attention indices with AIMS.

"These findings may have therapeutic implications, suggesting that female hormones, such as estrogen, may be useful in the prevention for the development of TD and impairment of cognitive function," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted May 2023

Read this next

Higher Olive Oil Intake Tied to Lower Risk for Dementia-Related Death

WEDNESDAY, May 8, 2024 -- Higher olive oil intake is associated with a lower risk for dementia-related mortality in U.S. adults, according to a study published online May 6...

Benefit of Thick Liquids in Alzheimer Disease and Dysphagia Unclear

MONDAY, May 6, 2024 -- For hospitalized patients with Alzheimer disease and related dementias (ADRD) and dysphagia, those receiving thick liquids are less likely to be intubated...

Cognitive Impairment Still Seen in Children, Teens With HIV

TUESDAY, April 30, 2024 -- Cognitive impairment persists in children and adolescents living with HIV even in the era of antiretroviral therapy (ART), according to research...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.